PL368055A1 - Postać krystaliczna fenyloetanoloaminy, sposób jej wytwarzania i zawierające ją środki farmaceutyczne - Google Patents
Postać krystaliczna fenyloetanoloaminy, sposób jej wytwarzania i zawierające ją środki farmaceutyczneInfo
- Publication number
- PL368055A1 PL368055A1 PL02368055A PL36805502A PL368055A1 PL 368055 A1 PL368055 A1 PL 368055A1 PL 02368055 A PL02368055 A PL 02368055A PL 36805502 A PL36805502 A PL 36805502A PL 368055 A1 PL368055 A1 PL 368055A1
- Authority
- PL
- Poland
- Prior art keywords
- phenylethanolamine
- preparation
- same
- pharmaceutical compositions
- crystalline form
- Prior art date
Links
- ULSIYEODSMZIPX-UHFFFAOYSA-N phenylethanolamine Chemical class NCC(O)C1=CC=CC=C1 ULSIYEODSMZIPX-UHFFFAOYSA-N 0.000 title 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 229950006768 phenylethanolamine Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C217/74—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C219/26—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Emergency Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0108562A FR2826651B1 (fr) | 2001-06-28 | 2001-06-28 | Forme cristalline d'une phenylethanolamine, sa preparation et compositions pharmaceutiques la contenant |
| PCT/FR2002/002235 WO2003002510A1 (fr) | 2001-06-28 | 2002-06-27 | Forme cristalline d'une phenylethanolamine, sa preparation et compositions pharmaceutiques la contenant |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL368055A1 true PL368055A1 (pl) | 2005-03-21 |
| PL206680B1 PL206680B1 (pl) | 2010-09-30 |
Family
ID=8864888
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL368055A PL206680B1 (pl) | 2001-06-28 | 2002-06-27 | Postać krystaliczna chlorowodorku [(7S)-7-[(2R)-2-(3-chlorofenylo)-2-hydroksyetyloamino]-5,6,7,8-tetrahydronaft-2-yloksy]octanu etylu, sposób jej wytwarzania i zawierający ją środek farmaceutyczny |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US6992211B2 (pl) |
| EP (1) | EP1404641B1 (pl) |
| JP (2) | JP4171413B2 (pl) |
| KR (1) | KR100869017B1 (pl) |
| CN (1) | CN1269797C (pl) |
| AR (1) | AR034648A1 (pl) |
| AT (1) | ATE403642T1 (pl) |
| AU (1) | AU2002333942B2 (pl) |
| BR (1) | BR0210661A (pl) |
| CA (1) | CA2450213C (pl) |
| CY (1) | CY1110099T1 (pl) |
| CZ (1) | CZ301450B6 (pl) |
| DE (1) | DE60228088D1 (pl) |
| DK (1) | DK1404641T3 (pl) |
| EE (1) | EE05380B1 (pl) |
| ES (1) | ES2307798T3 (pl) |
| FR (1) | FR2826651B1 (pl) |
| HU (1) | HUP0401229A3 (pl) |
| IL (2) | IL159134A0 (pl) |
| MX (1) | MXPA03011742A (pl) |
| NO (1) | NO331169B1 (pl) |
| NZ (1) | NZ530140A (pl) |
| PL (1) | PL206680B1 (pl) |
| PT (1) | PT1404641E (pl) |
| SI (1) | SI1404641T1 (pl) |
| SK (1) | SK287355B6 (pl) |
| TW (1) | TWI286129B (pl) |
| WO (1) | WO2003002510A1 (pl) |
| ZA (1) | ZA200309512B (pl) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2826651B1 (fr) * | 2001-06-28 | 2005-09-02 | Sanofi Synthelabo | Forme cristalline d'une phenylethanolamine, sa preparation et compositions pharmaceutiques la contenant |
| EP1623705A1 (en) * | 2004-07-09 | 2006-02-08 | Sanofi-Aventis | Use of phenylethanolaminotetralines for preparing anxiolytic drugs |
| FR2890862B1 (fr) * | 2005-09-19 | 2008-01-25 | Sanofi Aventis Sa | Association d'agoniste aux recepteurs beta 3 et d'inhibiteur de la recapture de monoamnies, compostion pharmaceutique la contenant et son utilisation en therapeutique. |
| EP4219749A3 (en) | 2015-12-30 | 2023-08-16 | Bio-Rad Laboratories, Inc. | Split-cycle and tape amplification |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3852589T2 (de) * | 1987-08-12 | 1995-08-10 | Sanofi Sa | Verfahren zur O-Alkylierung von N-(Hydroxy)aralkylphenylethanolamin. |
| US5235103A (en) * | 1987-08-12 | 1993-08-10 | Sanofi | Process for the preparation of phenylethanolaminotetralins |
| US5198586A (en) * | 1987-08-12 | 1993-03-30 | Sanofi | Process for the preparation of phenylethanolaminotetralins |
| US5202466A (en) | 1988-06-14 | 1993-04-13 | Sanofi | 2-amino-7-hydroxytetraline ethers |
| FR2643076B1 (fr) * | 1989-02-14 | 1991-06-21 | Midy Spa | Carboxyalkyl-ethers de la 2-amino-7-hydroxytetraline |
| FR2648042B1 (fr) * | 1989-06-13 | 1994-06-10 | Midy Spa | Utilisation de phenylethanolaminotetralines pour la preparation de medicaments pour le traitement des affections oculaires |
| US5312961A (en) * | 1989-02-14 | 1994-05-17 | Elf Sanofi | 2-amino-7-hydroxytetralin carboxylalkyl ethers |
| FR2669821A1 (fr) * | 1990-12-04 | 1992-06-05 | Sanofi Sa | Utilisation de phenylethanolaminotetralines pour la preparation de medicaments destines au traitement de la depression. |
| FR2826651B1 (fr) * | 2001-06-28 | 2005-09-02 | Sanofi Synthelabo | Forme cristalline d'une phenylethanolamine, sa preparation et compositions pharmaceutiques la contenant |
-
2001
- 2001-06-28 FR FR0108562A patent/FR2826651B1/fr not_active Expired - Fee Related
-
2002
- 2002-06-27 AT AT02780917T patent/ATE403642T1/de active
- 2002-06-27 CZ CZ20033531A patent/CZ301450B6/cs not_active IP Right Cessation
- 2002-06-27 DK DK02780917T patent/DK1404641T3/da active
- 2002-06-27 NZ NZ530140A patent/NZ530140A/en not_active IP Right Cessation
- 2002-06-27 CA CA2450213A patent/CA2450213C/en not_active Expired - Fee Related
- 2002-06-27 PT PT02780917T patent/PT1404641E/pt unknown
- 2002-06-27 TW TW091114166A patent/TWI286129B/zh not_active IP Right Cessation
- 2002-06-27 JP JP2003508694A patent/JP4171413B2/ja not_active Expired - Fee Related
- 2002-06-27 DE DE60228088T patent/DE60228088D1/de not_active Expired - Lifetime
- 2002-06-27 IL IL15913402A patent/IL159134A0/xx unknown
- 2002-06-27 EE EEP200400007A patent/EE05380B1/xx not_active IP Right Cessation
- 2002-06-27 SI SI200230728T patent/SI1404641T1/sl unknown
- 2002-06-27 AR ARP020102421A patent/AR034648A1/es active IP Right Grant
- 2002-06-27 HU HU0401229A patent/HUP0401229A3/hu unknown
- 2002-06-27 SK SK1593-2003A patent/SK287355B6/sk not_active IP Right Cessation
- 2002-06-27 AU AU2002333942A patent/AU2002333942B2/en not_active Ceased
- 2002-06-27 KR KR1020037016946A patent/KR100869017B1/ko not_active Expired - Fee Related
- 2002-06-27 BR BR0210661-2A patent/BR0210661A/pt not_active Application Discontinuation
- 2002-06-27 PL PL368055A patent/PL206680B1/pl not_active IP Right Cessation
- 2002-06-27 MX MXPA03011742A patent/MXPA03011742A/es active IP Right Grant
- 2002-06-27 ES ES02780917T patent/ES2307798T3/es not_active Expired - Lifetime
- 2002-06-27 EP EP02780917A patent/EP1404641B1/fr not_active Expired - Lifetime
- 2002-06-27 CN CNB028130952A patent/CN1269797C/zh not_active Expired - Fee Related
- 2002-06-27 WO PCT/FR2002/002235 patent/WO2003002510A1/fr not_active Ceased
- 2002-06-27 US US10/480,427 patent/US6992211B2/en not_active Expired - Fee Related
-
2003
- 2003-11-30 IL IL159134A patent/IL159134A/en not_active IP Right Cessation
- 2003-12-08 ZA ZA200309512A patent/ZA200309512B/xx unknown
- 2003-12-29 NO NO20035839A patent/NO331169B1/no not_active IP Right Cessation
-
2008
- 2008-07-08 JP JP2008178049A patent/JP4799592B2/ja not_active Expired - Fee Related
- 2008-09-24 CY CY20081101044T patent/CY1110099T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0303325A3 (en) | Pharmaceutical salts and pharmaceutical compositions containing them | |
| SI1381346T1 (sl) | Farmacevtski sestavki, ki vsebujejo formoterol | |
| EP1407785A4 (en) | MEDICAL COMPOSITIONS | |
| IL161623A (en) | Nicotin-or isonicotin benzothiazole derivatives, their preparation and pharmaceutical compositions comprising them | |
| GB0111597D0 (en) | Pharmaceutical compositions | |
| HUP0302847A3 (en) | Pharmaceutical formulation comprising bicalutamide | |
| HUP0401333A3 (en) | Spiropyrazole compounds and pharmaceutical compositions containing them | |
| PL367447A1 (pl) | Nowe pochodne 2h-pirydazyn-3-onu, zawierające je kompozycje farmaceutyczne oraz sposób otrzymywaniaskładnika aktywnego | |
| HUP0400850A3 (en) | Oral pharmaceutical compositions | |
| HUP0400179A3 (en) | 2,5-diarylpyrazines, 2,5-diarylpyridines and 2,5-diarylpyrimidines, their use and pharmaceutical compositions containing them | |
| IL160375A0 (en) | Pharmaceutical compositions comprising lumiracoxib | |
| GB0108470D0 (en) | Pharmaceutical compositions and their use | |
| IL161902A0 (en) | Pharmaceutical formulation comprising bicalutamide | |
| HUP0401713A3 (en) | Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same | |
| HUP0401644A3 (en) | Aminobenzoephenones, pharmaceutical compositions containing them and use thereof | |
| AU2002360117A1 (en) | Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same | |
| GB0104752D0 (en) | Pharmaceutical compositions | |
| HUP0303469A3 (en) | Phtalazinon-derivatives, their use and pharmaceutical compositions containing them | |
| HUP0301582A3 (en) | Calcilytic compounds and pharmaceutical compositions containing them | |
| IL159134A0 (en) | Crystalline form of a phenylethanolamine, the preparation thereof and pharmaceutical compositions comprising the same | |
| AU2002333942A1 (en) | Crystalline form of a phenylethanolamine, the preparation thereof and pharmaceutical compositions comprising the same | |
| IL162101A (en) | Crystalline form of a ribofuranosyluronamide derivative, pharmaceutical compositions comprising it, processes for its preparation and use thereof in the preparation of medicaments | |
| IL153176A (en) | Phenylpiperazines and pharmaceutical compositions comprising them | |
| IL158587A0 (en) | Novel 5-thio-ss-d-xylopyranoside derivatives, preparation method thereof, pharmaceutical compositions containing same and the therapeutic use thereof | |
| HUP0401406A3 (en) | Novel imidazolidine derivatives as vla-4 antagonists, their preparation their use and pharmaceutical compositions containing them |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RECP | Rectifications of patent specification | ||
| LAPS | Decisions on the lapse of the protection rights |
Effective date: 20120627 |